Bonus Biogroup Correlations
| BONS Stock | ILS 16.60 0.30 1.78% |
The correlation of Bonus Biogroup is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bonus Biogroup moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bonus Biogroup moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Modest diversification
The correlation between Bonus Biogroup and NYA is 0.22 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Bonus Biogroup and NYA in the same portfolio, assuming nothing else is changed.
Bonus |
The ability to find closely correlated positions to Bonus Biogroup could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bonus Biogroup when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bonus Biogroup - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bonus Biogroup to buy it.
Moving together with Bonus Stock
Moving against Bonus Stock
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Risk-Adjusted Indicators
There is a big difference between Bonus Stock performing well and Bonus Biogroup Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Bonus Biogroup's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| LUMI | 1.44 | (0.01) | (0.03) | (0.11) | 1.44 | 3.12 | 9.09 | |||
| MZTF | 1.67 | (0.07) | 0.00 | (0.23) | 0.00 | 4.01 | 11.57 | |||
| DSCT | 1.54 | 0.06 | 0.01 | (0.31) | 1.41 | 4.47 | 9.27 | |||
| MGDL | 1.66 | 0.15 | 0.04 | (0.24) | 1.96 | 3.61 | 11.72 | |||
| FIBIH | 1.44 | (0.01) | (0.03) | 0.38 | 1.59 | 2.76 | 11.80 | |||
| FIBI | 1.57 | 0.00 | (0.03) | 0.01 | 1.61 | 3.51 | 10.25 | |||
| CLIS | 1.39 | 0.06 | 0.01 | 0.46 | 1.72 | 2.80 | 10.39 | |||
| PHOE | 1.44 | 0.02 | (0.03) | 0.01 | 1.55 | 3.21 | 10.35 | |||
| HARL | 1.66 | 0.28 | 0.14 | 1.67 | 1.52 | 3.95 | 12.35 | |||
| MMHD | 1.28 | 0.00 | (0.02) | 0.06 | 1.26 | 3.46 | 6.98 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Bonus Biogroup without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Sign In To Macroaxis Now
Sign In To MacroaxisSign in to explore Macroaxis' wealth optimization platform and fintech modules |
| All Next | Launch Module |
Bonus Biogroup Corporate Directors
Bonus Biogroup corporate directors refer to members of a Bonus Biogroup board of directors. The board of directors generally takes responsibility for the Bonus Biogroup's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Bonus Biogroup's board members must vote for the resolution. The Bonus Biogroup board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Gil Shapira | Director | Profile | |
| Daniel BenLulu | Director | Profile | |
| Avi Slonim | External Director | Profile | |
| Yehuda Reznik | Director | Profile |
Already Invested in Bonus Biogroup?
The danger of trading Bonus Biogroup is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Bonus Biogroup is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Bonus Biogroup. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Bonus Biogroup is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bonus Biogroup. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Complementary Tools for Bonus Stock analysis
When running Bonus Biogroup's price analysis, check to measure Bonus Biogroup's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bonus Biogroup is operating at the current time. Most of Bonus Biogroup's value examination focuses on studying past and present price action to predict the probability of Bonus Biogroup's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bonus Biogroup's price. Additionally, you may evaluate how the addition of Bonus Biogroup to your portfolios can decrease your overall portfolio volatility.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |